Activated clotting time ( ACT ), also known as activated coagulation time is a test of coagulation . [ 1] The ACT test can be used to monitor anticoagulation effects, such as high-dose heparin before, during, and shortly after procedures that require intense anticoagulant administration, such as cardiac bypass , cardiac angioplasty , thrombolysis , extra-corporeal membrane oxygenation (ECMO) and continuous dialysis . [ 1] It measures the seconds needed for whole blood to clot upon exposure to an activator of an intrinsic pathway by the addition of factor XII activators. It is ordered in situations where the PTT test is not clinically useful (i.e., high-dose heparin therapy or presence of lupus anticoagulant). The ACT test is sometimes used, along with the PTT, to monitor the therapeutic effect of a direct thrombin inhibitor, such as argatroban or bivalirudin. The ACT is measured...